Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 6 (2009), Issue 11 (November)

1. Transarterial embolization of a scalp hemangioma presenting with Kasabach-Merritt syndrome.
   J Neurosurg Pediatr, 4(5): 453-7. [Abstract] [Full-text]
2. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma.
   J Natl Cancer Inst, 101(21): 1510-22. [Abstract] [Full-text]
3. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
   J Immunol, 183(10): 6330-7. [Abstract] [Full-text]
4. Regulation gone wrong: a subset of Sézary patients have malignant regulatory T cells.
   J Invest Dermatol, 129(12): 2747-50. [Abstract] [Full-text]
5. Analyzing the cost of preventing nonmelanoma skin cancer.
   J Invest Dermatol, 129(12): 2745-6. [Abstract] [Full-text]
6. Adoptive cell transfer in the treatment of metastatic melanoma.
   J Invest Dermatol, 129(12): 2743-5. [Abstract] [Full-text]
7. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.
   J Invest Dermatol, 129(12): 2875-85. [Abstract] [Full-text]
8. Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients.
   J Invest Dermatol, 129(12): 2886-94. [Abstract] [Full-text]
9. Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.
   J Invest Dermatol, 129(12): 2835-42. [Abstract] [Full-text]
10. Oral contraceptives: a risk factor for squamous cell carcinoma?
    J Invest Dermatol, 129(12): 2760-5. [Abstract] [Full-text]
11. Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals.
    J Invest Dermatol, 129(12): 2868-74. [Abstract] [Full-text]
12. Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells.
    J Invest Dermatol, 129(12): 2843-53. [Abstract] [Full-text]
13. Regular sunscreen use is a cost-effective approach to skin cancer prevention in subtropical settings.
    J Invest Dermatol, 129(12): 2766-71. [Abstract] [Full-text]
14. Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.
    Br J Cancer, 101(10): 1724-30. [Abstract] [Full-text]
15. Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding.
    J Gen Virol, 90: 2855-64. [Abstract] [Full-text]
16. De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation.
    Cancer Res, 69(22): 8662-9. [Abstract] [Full-text]
17. Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.
    J Biol Chem, 284(47): 32305-11. [Abstract] [Full-text]
18. The 'Sartorius Switch' and its relevance for the radiologist.
    J Plast Reconstr Aesthet Surg, 62(12): e578-9. [Abstract] [Full-text]
19. Pilomatrix carcinoma with visceral metastases: case report and review of the literature.
    J Plast Reconstr Aesthet Surg, 62(12): e574-7. [Abstract] [Full-text]
20. Reconstruction of the perioral and perinasal defects with facial artery perforator flaps.
    J Plast Reconstr Aesthet Surg, 62(12): 1616-20. [Abstract] [Full-text]
21. Future advances in melanoma research.
    Clin Plast Surg, 37(1): 169-76. [Abstract] [Full-text]
22. Surgical treatment of advanced melanoma.
    Clin Plast Surg, 37(1): 161-8. [Abstract] [Full-text]
23. Role of radiation therapy in cutaneous melanoma.
    Clin Plast Surg, 37(1): 147-60. [Abstract] [Full-text]
24. Systemic therapy for cutaneous melanoma.
    Clin Plast Surg, 37(1): 127-46. [Abstract] [Full-text]
25. Complete lymph node dissection for regional nodal metastasis.
    Clin Plast Surg, 37(1): 113-25. [Abstract] [Full-text]
26. Evaluation of sentinel lymph nodes for melanoma metastases by pathologists.
    Clin Plast Surg, 37(1): 101-12. [Abstract] [Full-text]
27. The role of lymphatic mapping and sentinel lymph node biopsy in the staging and treatment of melanoma.
    Clin Plast Surg, 37(1): 79-99. [Abstract] [Full-text]
28. Head and neck melanoma.
    Clin Plast Surg, 37(1): 73-7. [Abstract] [Full-text]
29. Surgical management of primary disease.
    Clin Plast Surg, 37(1): 65-71. [Abstract] [Full-text]
30. Melanoma: workup and surveillance.
    Clin Plast Surg, 37(1): 55-63. [Abstract] [Full-text]
31. Epidemiology, staging (new system), and prognosis of cutaneous melanoma.
    Clin Plast Surg, 37(1): 47-53. [Abstract] [Full-text]
32. Lentigo maligna: diagnosis and treatment.
    Clin Plast Surg, 37(1): 35-46. [Abstract] [Full-text]
33. The spitz nevus: review and update.
    Clin Plast Surg, 37(1): 21-33. [Abstract] [Full-text]
34. Pigmented lesion pathology: what you should expect from your pathologist, and what your pathologist should expect from you.
    Clin Plast Surg, 37(1): 1-20. [Abstract] [Full-text]
35. Successful radiation therapy for supratentorial primitive neuroectodermal tumor and epidermolysis bullosa simplex.
    Pediatr Blood Cancer, 54(1): 170-2. [Abstract] [Full-text]
36. Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs.
    Int J Cancer, 126(1): 11-8. [Abstract] [Full-text]
37. Immunomodulatory therapy of cutaneous T-cell lymphoma: a multimodality approach in advanced disease.
    J Am Acad Dermatol, 61(6): 1056-8. [Abstract] [Full-text]
38. Initial presentation of stasis dermatitis mimicking solitary lesions: a previously unrecognized clinical scenario.
    J Am Acad Dermatol, 61(6): 1028-32. [Abstract] [Full-text]
39. Surgical management of congenital dermatofibrosarcoma protuberans.
    J Am Acad Dermatol, 61(6): 1014-23. [Abstract] [Full-text]
40. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
    Proc Natl Acad Sci U S A, 106(46): 19473-8. [Abstract] [Full-text]
41. New insights into nevogenesis: in vivo characterization and follow-up of melanocytic nevi by reflectance confocal microscopy.
    J Am Acad Dermatol, 61(6): 1001-13. [Abstract] [Full-text]
42. Widespread porokeratotic adnexal ostial nevus: clinical features and proposal of a new name unifying porokeratotic eccrine ostial and dermal duct nevus and porokeratotic eccrine and hair follicle nevus.
    J Am Acad Dermatol, 61(6): 1060.e1-14. [Abstract] [Full-text]
43. Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients.
    J Am Acad Dermatol, 61(6): 993-1000. [Abstract] [Full-text]
44. CD30 expression and proliferative fraction in nontransformed mycosis fungoides.
    Am J Surg Pathol, 33(12): 1860-8. [Abstract] [Full-text]
45. Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors.
    Am J Surg Pathol, 33(12): 1771-7. [Abstract] [Full-text]
46. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Am J Surg Pathol, 33(12): 1783-8. [Abstract] [Full-text]
47. Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up.
    Am J Surg Pathol, 33(12): 1778-82. [Abstract] [Full-text]
48. Melanoma prognostic model using tissue microarrays and genetic algorithms.
    J Clin Oncol, 27(34): 5772-80. [Abstract] [Full-text]
49. Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.
    J Clin Oncol, 27(34): 5763-71. [Abstract] [Full-text]
50. PGP 9.5 and cyclin D1 coexpression in cutaneous squamous cell carcinomas.
    Int J Surg Pathol, 17(6): 413-20. [Abstract] [Full-text]
51. Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription.
    Mol Carcinog, 48(12): 1123-30. [Abstract] [Full-text]
52. Equine sarcoid fibroblasts over-express matrix metalloproteinases and are invasive.
    Virology, 396(1): 143-51. [Abstract] [Full-text]

© 2004-2012 Skin Cancer Research Today. All Rights Reserved.